|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
elderly
suspension for injection
immunocompromised patients
children under 5 years
adults over 50 years
|
|
gptkbp:age
|
adults
children
infants
|
|
gptkbp:approvalYear
|
2010
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:ATCCode
|
gptkb:J07AL02
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:brand
|
gptkb:Prevnar_13
|
|
gptkbp:broadcastOn
|
3-dose primary series plus booster
|
|
gptkbp:containsSerotype
|
gptkb:18C
gptkb:19F
gptkb:23F
1
14
3
4
5
6B
9V
6A
19A
7F
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
|
|
gptkbp:fullName
|
gptkb:Pneumococcal_13-valent_Conjugate_Vaccine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
PCV13
|
|
gptkbp:includedIn
|
adult immunization schedule
childhood immunization schedule
|
|
gptkbp:indication
|
prevention of invasive pneumococcal disease
prevention of pneumonia
prevention of otitis media
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:numberOfSerotypes
|
13
|
|
gptkbp:protectedBy
|
gptkb:Streptococcus_pneumoniae
|
|
gptkbp:replacedBy
|
gptkb:PCV7
|
|
gptkbp:routeOfAdministration
|
intramuscular
|
|
gptkbp:sideEffect
|
fever
fatigue
injection site pain
irritability
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:WHOModelListEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:vaccine
|
|
gptkbp:bfsLayer
|
4
|